Cellinfinity Bio
- | Biotech or pharma, therapeutic R&D
- | Synthesis, analytic, diagnostic services
- | Supplier, engineering
Cellinfinity is developing novel: 1) in situ (in vivo) CAR-T vectors and 2) multi-gene edited CAR-Ts against solid tumors.
Address
New HavenConnecticut
United States